HighField Biopharmaceuticals' HF1K16, a New Immuno-Oncology Drug, Shows Promise in Patients with Refractory Glioblastoma | Illinois
HANGZHOU, China--(BUSINESS WIRE)--May 31, 2023--
Source: wsiltv.com
Stay updated with breaking news from Field Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HANGZHOU, China--(BUSINESS WIRE)--May 31, 2023--